Results 211 to 220 of about 17,246 (287)

Bioresorbable biliary stents: A step forward. [PDF]

World J Clin Cases
Zhang LB, Wang Y, Yang XJ.
europepmc   +1 more source

The HRAS Variant c.175G>A (p.Ala59Thr) Causes a Predominantly Ectodermal Phenotype Lacking Classic Costello Syndrome Features

American Journal of Medical Genetics Part A, Volume 200, Issue 2, Page 407-418, February 2026.
ABSTRACT Costello syndrome (CS) is a rare dominant HRAS RASopathy characterized by curly hair, cardiac abnormalities, craniofacial anomalies, and developmental delay. HRAS codon 58, 59, and 60 variants are associated with milder phenotypes. We describe a three‐generation family with a previously unreported heterozygous HRAS variant c.175G>A (p.Ala59Thr)
Nikole Rautiainen, Eveliina Brandt, Kaisa Kettunen, Outi Elomaa, Sirpa Kivirikko, Leila Jeskanen, Katriina Lappalainen, Nelli Sjöblom, Juha Kere, Katariina Hannula‐Jouppi, Liisa Harjama   +10 more
wiley   +1 more source

Tracheostomy in Flap‐Based Head and Neck Cancer Surgery: A Meta‐Analysis of Indications and Adverse Outcomes

Head &Neck, Volume 48, Issue 2, Page 570-582, February 2026.
ABSTRACT Background Tracheostomy is frequently performed during flap‐based reconstruction for head and neck cancer, but predictive factors and complications are not well established. Methods A systematic review and meta‐analysis was conducted per PRISMA guidelines. Studies of adult patients undergoing free or pedicled flap reconstruction were included.
Raisa Chowdhury, Khanh Linh Tran, Naser Karimi, Jhorrit Kahlon, Cornelius Kürten, Sena Turkdogan, Eitan Prisman   +6 more
wiley   +1 more source

Current mechanisms and techniques for placement of self-expandable metal stents in acute colonic obstruction. [PDF]

World J Gastrointest Surg
Sun HY, Li ZC, Wang HL.
europepmc   +1 more source

Impact of Isovolemic Hemodilution‐Red Cell Exchange on Health‐Related Quality of Life in Patients With Sickle Cell Disease: A Pilot Study

Journal of Clinical Apheresis, Volume 41, Issue 1, February 2026.
ABSTRACT Sickle cell disease (SCD) negatively affects health‐related quality of life (HRQoL). Isovolemic hemodilution (IHD) red‐cell exchange (RCE) is being increasingly used to treat SCD‐related complications, but its impact on HRQoL has not been characterized.
Alistair Murray, Davinder Sidhu, Natalia Rydz, Dawn Goodyear, Kelsey Uminski   +4 more
wiley   +1 more source

Yield of next-generation sequencing in diagnostic work up of suspicious biliary strictures. [PDF]

Endosc Int Open
Meijering TLN, de Jong DM, Draijer S, Bruno MJ, Dubbink HJ, de Jonge J, van Velthuysen MF, van Driel LMJW.   +7 more
europepmc   +1 more source

18‐FDG PET in the Evaluation of Therapeutic Response of Necrotizing Otitis Externa

The Laryngoscope, Volume 136, Issue 2, Page 961-971, February 2026.
PET performed well in assessing the therapeutic response of NEO, with excellent sensitivity but low specificity of visual analysis. A complementary quantitative analysis was useful to distinguish between satisfactory and insufficient partial responses. ABSTRACT Objective The duration of antibiotic treatment for necrotizing otitis externa (NEO) and the ...
Lucie Lécolier, Philippine Toulemonde, Damien Huglo, Clio Baillet, Pauline Thill, Gauthier Delaby   +5 more
wiley   +1 more source

Non-Fistulizing Perianal Disease in Crohn's Disease: Clinical Significance, Pathogenesis, and Management Strategies. [PDF]

J Clin Med
Abreu Marques I, Cúrdia Gonçalves T, Macedo C, Campelo P, Cotter J.   +4 more
europepmc   +1 more source

The performance of biliary stents in malignant biliary strictures [PDF]

Bartosz Ostrowski, Tomasz Marek, Aleksandra Janczewska, Norbert Hajder, Artur Wiatrek, Ewa Nowakowska-Duława, Marek Hartleb   +6 more
openalex   +1 more source

Bowel Urgency Improvement Correlates With Clinical, Biochemical, and Intestinal Ultrasound Improvements in Inflammatory Bowel Disease: A Cross Sectional Multicenter Study

United European Gastroenterology Journal, Volume 14, Issue 1, February 2026.
ABSTRACT Background Bowel urgency (BU) is reported by over 80% of patients with ulcerative colitis (UC) and 60% of those with Crohn's disease (CD). However, the impact of advanced therapies on BU has not been consistently evaluated. Objectives To assess the effect of advanced therapies on BU improvement in patients with UC and CD.
Ferdinando D'Amico, Olga Maria Nardone, Alessandro Bruno, Mariangela Allocca, Alessandra Zilli, Federica Furfaro, Tommaso Lorenzo Parigi, Virginia Solitano, Federica Ungaro, Ilaria Faggiani, Alessia La Mantia, Giulio Calabrese, Gionata Fiorino, Vipul Jairath, Laurent Peyrin‐Biroulet, Luca Massimino, Fabiana Castiglione, Silvio Danese   +17 more
wiley   +1 more source